31 results
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
and supplier upon FDA approval of our product candidate. We have not determined the amounts we plan to spend on the areas listed above or the timing
8-K
EX-1.1
4nrqo tdcicoo
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
ipg oot8c
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
nez7wtg kc73e2
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
6u5f3
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
vse5nt1b4 gh2uzyz8tr
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
424B5
xihwdtw1jfn
9 Nov 21
Prospectus supplement for primary offering
5:14pm